PFG Investments’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$102K Buy
36,501
+1,800
+5% +$6.12K ﹤0.01% 1123
2025
Q4
$127K Buy
34,701
+6,282
+22% +$17.9K 0.01% 1076
2025
Q3
$105K Sell
28,419
-27,000
-49% -$68.3K 0.01% 1050
2025
Q2
$103K Buy
55,419
+10,160
+22% +$17.6K 0.01% 973
2025
Q1
$70.6K Buy
45,259
+10,000
+28% +$17.6K ﹤0.01% 956
2024
Q4
$71.4K Buy
35,259
+15,968
+83% +$28.9K ﹤0.01% 965
2024
Q3
$27.9K Buy
19,291
+3,000
+18% +$5.71K ﹤0.01% 991
2024
Q2
$27.9K Hold
16,291
﹤0.01% 913
2024
Q1
$32.6K Buy
+16,291
New +$32.4K ﹤0.01% 1008

Other funds holding FBIO

PFG Investments's FBIO Position: Q1 2026 in Review

PFG Investments increased its Fortress Biotech (FBIO) stake by 5.2% in Q1 2026, buying an estimated $6.12K and bringing the position to 36,501 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

PFG Investments first reported a position in FBIO in Q1 2024 and has held it in 9 quarters since. The position peaked at $127K in Q4 2025. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • PFG Investments held 36,501 shares of Fortress Biotech worth $102K as of Q1 2026.
  • PFG Investments bought 1,800 Fortress Biotech shares in Q1 2026, an estimated $6.12K.
  • Fortress Biotech made up ﹤0.01% of PFG Investments's portfolio in Q1 2026, its #1123 holding.
  • PFG Investments first reported a position in Fortress Biotech in Q1 2024 and has held it in 9 quarters since.
  • PFG Investments's Fortress Biotech position peaked at $127K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on PFG Investments's 13F filing for Q1 2026, filed 27 Apr 2026.